Atherosclerosis: Known and unknown.
Fan J, Watanabe T.
Pathol Int. 2022 Mar;72(3):151-160. doi: 10.1111/pin.13202. Epub 2022 Jan 25.
The changing landscape of atherosclerosis.
Libby P.
Nature. 2021 Apr;592(7855):524-533. doi: 10.1038/s41586-021-03392-8. Epub 2021 Apr 21.
Research Progress on the Relationship between Atherosclerosis and Inflammation.
Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, Tang D, Chen R.
Biomolecules. 2018 Aug 23;8(3):80. doi: 10.3390/biom8030080.
Atherosclerosis.
Kobiyama K, Ley K.
Circ Res. 2018 Oct 26;123(10):1118-1120. doi: 10.1161/CIRCRESAHA.118.313816.
LDL cholesterol as a causal agent of atherosclerosis.
Pedro-Botet J, Climent E, Benaiges D.
Clin Investig Arterioscler. 2024 Dec;36 Suppl 1:S3-S8. doi: 10.1016/j.arteri.2024.07.001. Epub 2024 Jul 22.
Atherosclerosis Reviewed.
Erol Ç.
Anatol J Cardiol. 2024 Aug;28(8):374. doi: 10.14744/AnatolJCardiol.2024.8.
Progress and challenges in translating the biology of atherosclerosis.
Libby P, Ridker PM, Hansson GK.
Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146.
Small rodent models of atherosclerosis.
Zhao Y, Qu H, Wang Y, Xiao W, Zhang Y, Shi D.
Biomed Pharmacother. 2020 Sep;129:110426. doi: 10.1016/j.biopha.2020.110426. Epub 2020 Jun 20.
The immune system in atherosclerosis.
Hansson GK, Hermansson A.
Nat Immunol. 2011 Mar;12(3):204-12. doi: 10.1038/ni.2001.
Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets.
Wang C, Li Z, Liu Y, Yuan L.
Theranostics. 2021 Feb 15;11(8):3996-4010. doi: 10.7150/thno.56035. eCollection 2021.
